文献速递浆细胞疾病

初诊多发性骨髓瘤早期死亡风险预测模型

[A predictive model based on risk factors for early mortality in patients with newly diagnosed multiple myeloma].
PubMed 文献 · Zhonghua Xue Ye Xue Za Zhi · 2021-01-01

该研究回顾性分析275例初诊多发性骨髓瘤患者,确定6、12、24个月早期死亡率分别为5.5%、12.7%、30.2%,主要死因为疾病进展/复发。基于年龄>75岁、血小板<100×10^9/L和1q21 gain三个独立危险因素建立24个月早期死亡预测模型,积分≥3分患者死亡风险是低危者的26倍,并可预测总生存。

要点

  • 初诊骨髓瘤24个月早期死亡率为30.2%,主要原因为疾病进展/复发。
  • 年龄>75岁、血小板<100×10^9/L和1q21 gain是24个月早期死亡的独立危险因素。
  • 预测模型积分≥3分者24个月死亡风险为低积分者的26倍,且可区分总生存。

核心结论

  • 年龄>75岁、血小板<100×10^9/L和1q21 gain是初诊多发性骨髓瘤患者24个月早期死亡的独立预后因素。
  • 基于上述三个因素构建的预测模型有助于识别早期死亡风险并预测生存。

研究设计与样本

  • 回顾性分析2009年5月至2017年1月吉林大学白求恩第一医院收治的275例初诊多发性骨髓瘤患者。
  • 对6、12、24个月早期死亡患者初诊时基线特征进行单因素和多因素分析,并建立预测模型。

主要发现

  • 6、12、24个月早期死亡率分别为5.5%、12.7%和30.2%。
  • 6、12、24个月早期死亡中最常见死因为疾病进展/复发,分别占60.0%、77.1%和84.3%。
  • 6个月早期死亡相关因素包括校正血清钙>2.75 mmol/L和血小板<100×10^9/L。
  • 12个月早期死亡相关因素包括年龄>75岁、ISS Ⅲ期、R-ISS Ⅲ期、校正钙>2.75 mmol/L、血清肌酐>177 μmol/L、血小板<100×10^9/L及骨髓浆细胞比例≥60%。
  • 24个月早期死亡相关因素除上述12个月因素外,还包括男性和1q21 gain;多因素分析显示年龄>75岁、血小板<100×10^9/L和1q21 gain为独立危险因素。

关键数值与推荐

  • 预测模型赋分:年龄>75岁1分,血小板<100×10^9/L 2分,1q21 gain 1分;积分≥3分为高危。
  • 模型ROC曲线下面积为0.709(95%CI 0.626~0.793)。
  • 积分≥3分患者24个月内死亡风险是0~2分患者的26倍。
  • 积分0、1、2、3、4分患者中位总生存期分别为59、41、22、17.5、16个月(P<0.001)。

临床怎么用

  • 对初诊多发性骨髓瘤患者评估年龄、血小板计数和1q21 gain,计算积分以识别24个月早期死亡高危患者。
  • 高危患者(积分≥3分)可考虑更密切监测和强化治疗策略。

局限性

  • 单中心回顾性研究,样本量有限。
  • 模型灵敏度20.7%、特异度99.2%,灵敏度较低。
  • 未发现6个月和12个月早期死亡的独立危险因素。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Objective: To investigate risk factors for early mortality (EM) in patients with newly diagnosed multiple myeloma (NDMM) and to build an EM-predictive model. Methods: In a cohort of 275 patients with NDMM, risk factors for EM at 6, 12, and 24 months after diagnosis (EM6, EM12, and EM24, respectively) were determined to establish a model to predict EM. Results: The rates of EM6, EM12, and EM24 were 5.5% , 12.7% , and 30.2% , respectively. The most common cause for EM was disease progression/relapse, accounting for 60.0% , 77.1% , and 84.3% of EM6, EM12, and EM24, respectively. EM6 was associated with corrected serum calcium >2.75 mmol/L and platelet count <100×10(9)/L, whereas risk factors for EM12 included age >75 years, ISS Ⅲ, R-ISS Ⅲ, corrected serum calcium >2.75 mmol/L, serum creatinine >177 µmol/L, platelet count <100×10(9)/L, and bone marrow plasma cell ratio ≥ 60% . In addition to the risk factors for EM12, EM24 was also associated with male sex and 1q21 gain. By multivariate analysis, age >75 years, platelet count <100×10(9)/L, and 1q21 gain were independent risk factors for EM24 but there were no independent risk factors significantly associated with EM6 and EM12. Using a scoring system including these three risk factors, a Cox model for EM24 was generated to distinguish patients with low (score<3) and high (score ≥ 3) risk. The sensitivity and specificity of the model were 20.7% and 99.2% , respectively. Further, an internal validation performed in a cohort of 183 patients with NDMM revealed that the probability of EM24 in high-risk patients was 26 times higher than that in low-risk patients. Moreover, this model was also able to predict overall survival. The median overall survival of patients with scores of 0, 1, 2, 3, 4, and 5 were 59, 41, 22, 17.5, and 16 months, respectively. Conclusion: In the study cohort, the EM6, EM12, and EM24 rates were 5.5% , 12.7% , and 30.2% , respectively, and disease progression or relapse were main causes of EM. An EM24-predictive model built on three independent risk factors for EM24 (age>75 years, platelet count<100×10(9)/L, and 1q21 gain) might predict EM risk and overall survival. 目的: 分析影响初治多发性骨髓瘤(NDMM)患者早期死亡(EM)的因素,建立其预测模型,以期识别EM风险。 方法: 回顾性分析2009年5月至2017年1月吉林大学白求恩第一医院收治的275例NDMM患者,对6个月(EM6)、12个月(EM12)及24个月(EM24)内死亡患者初诊时基线特征进行单因素分析,并根据多因素分析结果建立EM的预测模型。 结果: 本研究中EM6、EM12及EM24的发生率分别是5.5%、12.7%和30.2%;最常见的死亡原因为疾病复发/进展,在EM6、EM12及EM24中分别占60.0%、77.1%及84.3%。影响EM6的因素包括经白蛋白校正的血清钙(校正钙)>2.75 mmol/L和PLT<100×10(9)/L;影响EM12的因素包括年龄>75岁、国际分期系统(ISS) Ⅲ期、修订版国际分期系统(R-ISS) Ⅲ期、校正钙>2.75 mmol/L、血清肌酐>177 μmol/L、PLT<100×10(9)/L及骨髓浆细胞比例≥60%;影响EM24的因素中,除上述影响EM12的因素外,还包括男性和染色体核型1q+。多因素分析尚未发现EM6和EM12的独立预后因素。在EM24的多因素分析中,年龄>75岁、PLT<100×10(9)/L和染色体核型1q+是EM24的独立预后因素。根据Logistic回归系数赋分:年龄>75岁:1分;PLT<100×10(9)/L:2分;染色体核型1q+:1分,建立EM24预测模型,ROC曲线下面积为0.709(95%CI 0.626~0.793)。积分≥3分的患者24个月内死亡风险是0~2分患者的26倍,积分0~4分的NDMM患者中位总生存期分别为59、41、22、17.5及16个月(P<0.001)。 结论: 年龄>75岁、PLT<100×10(9)/L和染色体核型1q+为EM24的独立预后因素,依据上述变量构建的EM24预测模型有助于识别EM风险和预测生存,具有较好标准度与区分度。.

来源:Zhonghua Xue Ye Xue Za Zhi,查看原文。版权归原作者所有。

引用

  1. Tian MR, Yang PY, Yue TT, et al. [A predictive model based on risk factors for early mortality in patients with newly diagnosed multiple myeloma]. Zhonghua Xue Ye Xue Za Zhi. 2021. PMID: 34547873. doi:10.3760/cma.j.issn.0253-2727.2021.08.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。